Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kairos Pharma (KAPA) Return on Equity (2024 - 2025)

Kairos Pharma's Return on Equity history spans 2 years, with the latest figure at 0.67% for Q4 2025.

  • For Q4 2025, Return on Equity rose 5.0% year-over-year to 0.67%; the TTM value through Dec 2025 reached 0.67%, up 5.0%, while the annual FY2025 figure was 0.98%, N/A changed from the prior year.
  • Return on Equity reached 0.67% in Q4 2025 per KAPA's latest filing, up from 0.77% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.65% in Q1 2025 to a low of 0.77% in Q2 2025.